The paper reports two primary empirical components: (1) an in-house indirect ELISA of alpha-Gal content across arthropod and mollusk taxa, finding the epitope in cuttlefish (Sepia species) but absent in poultry red mite, pavement ant, European hornet, squids, and pharaoh cuttlefish; and (2) a UniProt database survey of GGTA1 (1,3-galactosyltransferase) showing sequences in all examined Arthropoda/Nematoda taxa except scorpions β notably Orthoptera (3 sequences) and Coleoptera (80 sequences) despite reported alpha-Gal negativity, which the authors themselves acknowledge may reflect incomplete N-glycan Golgi maturation . These are modest, descriptive findings β no sample sizes, no quantified ELISA values, no replicates reported.
The central evolutionary hypothesis β bacterial origin ca. 1000 Mya in stromatolite-associated Proteobacteria, Triassic expansion after the Permian-Triassic "Great Dying," and Oligocene hominid GGTA1 inactivation β rests on correlating modern trait presence with fossil dates, a method the authors do not validate with molecular-clock or phylogenomic analysis . Inferring deep-time gene origins from present-day taxon positivity is an over-generalization: convergent evolution, horizontal transfer, and differential gene loss are not distinguished.
The claim that non-tick organisms (mosquitoes, chiggers, wasps, nematodes) may broaden AGS exposure is consistent with prior evidence that tick bites drive alpha-gal IgE sensitization and with mosquito-sensitization hypotheses . However, the paper presents no AGS incidence or epidemiological data of its own; the "growing risk" framing relies on external epidemiology. Notably, only a subset of sensitized individuals develop clinical AGS, and pathophysiology of that conversion remains unresolved .
Confidence note: the descriptive ELISA/UniProt findings are plausible but under-reported; the deep-time evolutionary hypothesis is conjecture weighted by narrative, not tested inference.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.